Pacific Biosciences Of California (PACB) Property, Plant & Equipment (Net) (2010 - 2026)
Pacific Biosciences Of California (PACB) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 12.81 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 3.96 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 7.42 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 4.13 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 1.84 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 1.58 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 3.15 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 2.52 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 2.17 Bn |
| 10 | Pacific Biosciences Of California | 396.09 Mn | 159.21 Mn | 12.64 Mn | 26.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.97 Mn |
| Jun 30, 2026 | 26.97 Mn |
| Mar 31, 2026 | 24.38 Mn |
| Mar 31, 2026 | 24.38 Mn |
| Dec 31, 2025 | 24.15 Mn |
| Dec 31, 2025 | 24.15 Mn |
| Sep 30, 2025 | 22.13 Mn |
| Sep 30, 2025 | 22.13 Mn |
| Jun 30, 2025 | 23.10 Mn |
| Jun 30, 2025 | 23.10 Mn |
| Mar 31, 2025 | 24.79 Mn |
| Mar 31, 2025 | 24.79 Mn |
| Dec 31, 2024 | 30.51 Mn |
| Dec 31, 2024 | 30.51 Mn |
| Sep 30, 2024 | 31.95 Mn |
| Sep 30, 2024 | 31.95 Mn |
| Jun 30, 2024 | 34.91 Mn |
| Jun 30, 2024 | 34.91 Mn |
| Mar 31, 2024 | 37.29 Mn |
| Mar 31, 2024 | 37.29 Mn |